Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KB(V200)

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 177-184

  Li, Zhu Hong ^a,b   Zhu, Ya Jun ^a   Lit, Xue Tang ^a  

^a CANCER HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Anticancer drug; Apoptosis; Drug resistance; MDR1 gene; p53 gene

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; PROTEIN P53; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL STRAIN KB; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; GENES, P53; GLYCOPROTEINS; HUMANS; KB CELLS; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSFECTION; UP-REGULATION;

EID: 0030662414     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00267-X     Document Type: Article

References (35)

1. J.A. Endicott, V. Ling, The biochemistry of P-glycoprotein-mediated multidrug resistance, Annu. Rev. Biochem. 58 (1989) 137-171.
2. M.M. Gottesman, I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62 (1993) 385-427.
3. A.T. Fojo, K. Ueda, D.J. Slamon, D.G. Poplack, M.M. Gottesman, I. Pastan, Expression of a multidrug-resistance gene in human tumors and tissues, Proc. Natl. Acad. Sci. USA 84 (1987) 265-269.
4. K.V. Chin, S.S. Chauhan, I. Pastan, M.M. Gottesman, Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells, Cell Growth Diff. 1 (1990) 361-365.
5. P.M. Chaudhary, I.B. Raninson, Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs, J. Natl. Cancer Inst. 85 (1993) 632-639.
6. K. Kohno, S. Sato, H. Takano, K. Matsuo, M. Kuwano, The direct activation of human multidrug resistance gene (MDR1) by anticancer agents, Biochem. Biophys. Res. Commun. 165 (1989) 1415-1421.
7. T. Uchhiumi, K. Kohno, H. Tanimura, K. Matsuo, S. Sato, Y. Uchida, M. Kuwano, Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation, Cell Growth Diff. 4 (1993) 147-157.
8. K.V. Chin, S. Tanaka, G. Darlington, I. Pastan, M.M. Gottesman, Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells, J. Biol. Chem. 265 (1990) 221-226.
9. S.W. Lowe, H.E. Ruley, T. Jacks, D.E. Housman, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents, Cell 74 (1993) 957-967.
10. M.E. Goldsmith, J.M. Gudas, E. Schneider, K.H. Cowan, Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line, J. Biol. Chem. 270 (1995) 1894-1898.
11. K.V. Chin, K. Ueda, I. Pastan, M.M. Gottesman, Modulation of activity of the promoter of the human MDR1 gene by Ras and p53, Science 255 (1992) 459-462.
12. R.L. Zastawny, R. Salvino, J. Chen, S. Benchimol, V. Ling, The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53, Oncogene 8 (1993) 1529-1535.
13. J. Lin, A.K. Teresky, A.J. Levine, Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants, Oncogene 10 (1995) 2387-2390.
14. X.H. Zhang, F.Y. Zhang, X.J. Ji, Z.Y. Li, Vincristine-resistance human KB cells and mechanism of multidrug resistance, Acta Pharm. Sinica 29 (1994) 245-251.
15. J. Price, D. Turner, C. Cepko, Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer, Proc. Natl. Acad. Sci USA 84 (1987) 156-160.
16. T. Maniatis, E.F. Fritsch, J. Sambrook, Isolation of high-molecular weight DNA from mammalian cells, in: N. Ford, C. Nolan, M. Ferguson (Eds.), Molecular Cloning: A Laboratory Manual, Vol. 1, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 9.14-9.30.
17. T. Maniatis, E.F. Fritsch, J. Sambrook, Isolation of total RNA by extraction with strong denaturants, in: N. Ford, C. Nolan, M. Ferguson (Eds.), Molecular Cloning: A Laboratory Manual, Vol. 1, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 7.18-7.22.
18. T. Grogan, W. Dalton, J. Rybski, C. Spier, P. Meltzer, L. Richhter, M. Gleason, J. Pindur, A. Cline, R. Scheper, T. Tsuruo, S. Salmon, Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma myeloma using three antibodies, Lab. Invest. 63 (1990) 815-824.
19. D.A. Scudiero, R.H. Shoemaker, K.D. Paul, A. Monks, S. Tierney, T.H. Nofziger, M.J. Currens, D. Seniff, M.R. Boyd, Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines, Cancer Res. 48 (1988) 4827-4833.
20. S.K. Chambers, W.N. Hait, B.M. Kacinski, S.R. Keyes, R.E. Handschumacher, Enhancement of anthracycline growth inhibition in parent and MDR Chinese hamster ovary cells by cyclosporin A and its analogues, Cancer Res. 49 (1989) 6275-6279.
21. B. Jimémez, M. Arends, P. Esteve, R. Perona, R. Sánchez, S.R. Cajal, A. Wyllie, J.C. Lacal, Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily, Oncogene 10 (1995) 811-816.
22. F. Traganos, J. Kapusscinski, J. Gong, B. Ardelt, R.J. Darzynkiewicz, Z. Darzynkiewicz, Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells, Cancer Res. 53 (1993) 4613-4618.
23. R. Brown, C. Clugston, P. Burns, P. Burns, A. Edlin, P. Vasey, B. Vojtêšek, S. Kaye, Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines, Int. J. Cancer 55 (1993) 678-683.
24. S.W. Lowe, S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, T. Jacks, p53 status and the efficacy of cancer therapy in vivo, Science 266 (1994) 807-810.
25. S. Thorlacius, A.L. Borresen, J.E. Eyfjord, Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor, Cancer Res. 53 (1993) 1637-1641.
26. C.A. Felix, M.M. Nau, T. Takahashi, T. Mitsudomi, I. Chiba, D.G. Poplack, G.H. Reaman, D.E. Cole, J.I. Letterio, J. Whang-peng, T. Knutsen, J.D. Minna, Hereditary and acquired p53 gene mutations in children acute lymphoblastic leukemia, J. Clin. Invest. 89 (1992) 640-647.
27. M. Peoc'h, E. Brambilla, D. Moro, S. Gazzeri, C. Brambilla, Respective roles of the products of the MDR1 and p53 genes in drug resistance of bronchial cancers, Bull. Cancer (Paris) 81 (Suppl. 2 )(1994) 98s-104s.
28. G. Bradley, V. Ling, P-glycoprotein multidrug resistance and tumor progression, Cancer Metastasis 13 (1994) 223-233.
29. S.C. Linn, A. Honkoop, K. Hoekman, P. van der Valk, H.M. Pinedo, G. Giaccone, Coexpression of P-glycoprotein and mutant p53 in operable and locally advanced breast cancer (meeting abstract), Proc. Annu. Meet. Am. Assoc. Cancer Res. 36 (1995) A1296.
30. S. El Rouby, A. Thomas, D. Costin, C.R. Rosenberg, M. Potmesil, R. Silber, E.W. Newcomb, p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression, Blood 82 (1993) 3452-3459.
31. K. Campbell, B.W. Futscher, T.M. Grogan, W.S. Dalton, Frequency of p53 mutations in multiple myeloma and association with drug resistance (meeting abstract), Proc. Annu. Meet. Am. Assoc. Cancer Res. 36 (1995) A1293.
32. T. Fujiwara, E.A. Grimm, T. Mukhopadhyay, W.W. Zhang, L.B. Owen-Schaub, J.A. Roth, Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene, Cancer Res. 54 (1994) 2287-2291.
33. E. Yonish-Rouach, D. Resnitzky, J. Rotem, L. Sachs, A. Kimchi, M. Oren, Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6, Nature 352 (1991) 345-347.
34. P. Shaw, K. Bovey, S. Tardy, R. Sahli, B. Sordat, J. Costa, Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell-line, Proc. Natl. Acad. Sci. USA 89 (1992) 4495-4499.
35. T. Ramqvist, K.P. Magnusson, Y. Wang, L. Szekeley, G. Klein, Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53, Oncogene 8 (1993) 1495-1500.